

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| May 29, 26 | Thomas John T | director | A-Award | 1,385 @ $15.46 | $21.41K |
| May 29, 26 |
| Thomas John T |
| director |
| F-InKind |
| 78 @ $19.15 |
| $1.49K |
| May 29, 26 | Patadia Ankit B. | officer: EVP and Treasurer | A-Award | 1,358 @ $15.46 | $21.00K |
| May 29, 26 | Patadia Ankit B. | officer: EVP and Treasurer | F-InKind | 94 @ $19.15 | $1.80K |
| May 29, 26 | Moses Kelvin O | officer: Chief Financial Officer | A-Award | 937 @ $15.46 | $14.49K |
| May 29, 26 | Moses Kelvin O | officer: Chief Financial Officer | F-InKind | 65 @ $19.15 | $1.24K |
| May 29, 26 | Mabry Adam G | officer: CIO | A-Award | 625 @ $15.46 | $9.66K |
| May 29, 26 | Mabry Adam G | officer: CIO | F-InKind | 43 @ $19.15 | $823 |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
October's top ten monthly-pay dividend equities offer forecasted net gains from 28.06% to 89.66% by 2027, with an average gain of 50.94%. Banco BBVA Argentina (BBAR) and Banco Macro (BMA) lead the MoPay group, with analyst targets implying the highest total returns and significant price upsides. Yield-based MoPay stock selection proved 70–80% accurate versus analyst upside forecasts, favoring financial and real estate sectors for both yield and price appreciation.
Rate Shock: REITs enter earnings season on their back foot amid a renewed surge in long-term rates, facing a materially different cost-of-capital and financing environment than just three months ago. The rate surge is again stressing highly leveraged borrowers, particularly across private markets. Public REITs are better positioned, but remain exposed through refinancing, tenant credit, and equity valuations. Higher rates have brought an important silver lining: years of expensive capital are finally curbing construction, with shrinking pipelines beginning to support occupancy, rents, and landlord pricing power.
SteelPeak Wealth LLC increased its holdings in Healthpeak Properties, Inc. (NYSE: DOC) by 62.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,979 shares of the real estate investment trust's stock after purchasing an additional 35,251 shares during the quarter.
Farther Finance Advisors LLC grew its stake in Healthpeak Properties, Inc. (NYSE: DOC) by 393.2% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 123,454 shares of the real estate investment trust's stock after acquiring an additional 98,423 shares during the period. Farther Finance Advisors
Healthpeak Properties offers a compelling 6.5% monthly dividend yield, supported by a BBB+ balance sheet and well-covered payout ratio. DOC trades at 10.65x forward FFO, well below its historical P/FFO of 14.0, presenting an attractive entry point after a recent dip. Outpatient medical and senior housing segments deliver steady results, while life science occupancy shows early signs of recovery amid sector headwinds.
I spotlight nine 'safer' S&P 500 Dogs, including VICI, KHC, and PFE, as prime dividend opportunities with strong free cash flow coverage. Analyst projections indicate top-ten S&P 500 Dogs could deliver 17.5%–33.2% net gains by October 2027, with a 37.1% average net gain across the group. Seven of the top ten 'safer' Dogs already meet the fair price standard, with only modest corrections needed for the remainder to align with ideal yield metrics.
EPR Properties, Healthpeak Properties, and Chiron Real Estate offer safe, high-yield monthly dividends with strong coverage and retained earnings. EPR targets experiential assets, shrinking cinema exposure, and boasts a 6.8% yield with a 65% AFFO payout ratio, supporting future growth and balance sheet strength. DOC focuses on life science and outpatient medical properties, leveraging current sector weakness for long-term AFFO growth, with an 80% AFFO payout ratio and 6.6% yield.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 0.03 | 0.08 | Beat 184.2% | $749.8M |
| May 5, 2026 | 0.05 | 0.28 | Beat 430.7% | $738.8M |
| Feb 2, 2026 | 0.45 | 0.16 | Miss -64.4% | $704.8M |
| Oct 23, 2025 | 0.06 | -0.17 | Miss -383.3% | $690.3M |
| Jul 24, 2025 | 0.06 | 0.05 | Miss -21.9% | $678.5M |
| Apr 24, 2025 | 0.05 | 0.06 | Beat 11.7% | $702.9M |
TTM vs. 5-year historical average (annual ratios)
| Metric | DOC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 55.0x | 63.7x · sector 35.5x | Elevated |
| Forward P/E (FY26E) | 41.7x | EPS est. 0.46 | Discount |
| Price / Book | 1.7x | 2.0x | In line |
| Price / Sales | 4.5x | 6.2x | Discount |
| EV / EBITDA | 12.6x | 16.7x | Discount |
| Return on equity | 3.3% | — | Weak |
| Gross margin | 2.5% | 51.7% | Below hist. |
| Debt / Equity | 1.32 | 1.11 | Moderate |
| Piotroski / Altman Z | 7/9 | Z 0.96 | Distress |
Discounted cash flow model
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 48.23 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 54.93 | Oscillator | Neutral |
| Williams %R (14) | -24.37 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.35 (Hist 0.09) | Oscillator | Buy |
| Average Directional Index (14) | 33.40 (+DI 18.3 / -DI 21.4) | Trend |
| EMA 20 | 19.19 | MA | Buy |
| SMA 20 | 19.09 | MA | Buy |
| EMA 50 | 19.81 | MA | Sell |
| SMA 50 | 20.08 | MA | Strong Sell |
| SMA 200 | 19.08 | MA | Buy |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G | Aug 7, 2026 | 2026-08-07 09:47:44 | View |
| 10-Q | Aug 5, 2026 | 2026-08-05 16:16:54 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 16:19:14 | View |
| SC 13G/A | Jul 22, 2026 | 2026-07-22 13:29:56 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:25:33 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:25:02 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:24:40 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:24:05 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:23:41 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:23:03 | View |
Proxy statement (DEF 14A) disclosures
Current price $19.25
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 19, 26 |
| Wells Fargo |
| maintain |
| Equal Weight |
| Equal Weight |
| Oct 13, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Oct 13, 26 | UBS | maintain | Neutral | Neutral |
| Sep 21, 26 | Evercore ISI Group | maintain | In Line | In Line |
| Aug 31, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Aug 13, 26 | Baird | maintain | Outperform | Outperform |
| Aug 11, 26 | Citigroup | maintain | Neutral | Neutral |
| Aug 10, 26 | RBC Capital | maintain | Outperform | Outperform |
| Aug 6, 26 | Cantor Fitzgerald | maintain | Neutral | Neutral |